The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. Tissue-level model of human airway musculature could pave way for patient-specific asthma treatments
New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people in the United States alone to wheeze, cough, and find it difficult at best to take a deep breath.
But finding new treatments is tough: asthma is a patient-specific disease, so what works for one person doesn’t necessarily work for another, and the animal models traditionally used to test new drug candidates often fail to mimic human responses–costing tremendous money and time.
Hope for healthier airways may be on the horizon thanks to a Harvard University team that has developed a human airway muscle-on-a-chip that could be used to test new drugs because it accurately mimics the way smooth muscle contracts in the human airway, under normal circumstances and when exposed to asthma triggers. As reported in the journal Lab on a Chip, it also offers a window into the cellular and even subcellular responses within the tissue during an asthmatic event.
“Every year asthma costs many tens of billions of dollars, significant productivity due to lost work and school days, and even lives,” said senior author Kevin Kit Parker, Ph.D., a Core Faculty member at Harvard’s Wyss Institute for Biologically Inspired Engineering and Tarr Family Professor of Bioengineering and Applied Physics at the Harvard School of Engineering and Applied Sciences (SEAS). Parker leads development of the Wyss Institute’s heart-on-a-chip technology as well and is specifically interested in diseases that affect children. “We were thrilled with how well the chip recapitulated the functioning of the human airway.”
The chip, a soft polymer well that is mounted on a glass substrate, contains a planar array of microscale, engineered human airway muscles, designed to mimic the laminar structure of the muscular layers of the human airway.
To mimic a typical allergic asthma response, the team first introduced interleukin-13 (IL-13) to the chip. IL-13 is a natural protein often found in the airway of asthmatic patients that mediates the response of smooth muscle to an allergen.
Then they introduced acetylcholine, a neurotransmitter that causes smooth muscle to contract. Sure enough, the airway muscle on the chip hypercontracted – and the soft chip curled up – in response to higher doses of the neurotransmitter.
They achieved the reverse effect as well and triggered the muscle to relax using drugs called ?-agonists, which are used in inhalers.
Significantly, they were able to measure the contractile stress of the muscle tissue as it responded to varying doses of the drugs, said lead author Alexander Peyton Nesmith, a Ph.D./M.D. student at Harvard SEAS and the University of Alabama at Birmingham. “Our chip offers a simple, reliable and direct way to measure human responses to an asthma trigger,” he said.
The Latest on: Asthma
via Google News
The Latest on: Asthma
- Norton teen begins therapy after asthma attack at homecoming danceon November 29, 2019 at 2:43 pm
Emma Pfouts has been moved into a cardiac chair and is set to begin physical therapy after suffering an asthma attack at the North High School homecoming dance.
- What Is Severe Asthma?on November 28, 2019 at 6:21 am
Severe asthma is a form of the condition that isn't easily controlled, says Dr. Thomas Slobig, an adult pulmonary physician in private practice in Gilbert, Arizona. Nationwide, more than 25 million ...
- Asthma Control Is Critical During Pregnancyon November 27, 2019 at 4:37 pm
Pregnant women with asthma should take special care to keep their asthma in check. Canadian researchers have found that asthma attacks during pregnancy are associated with a number of serious health ...
- Asthma exacerbations may worsen pregnancy outcomeson November 27, 2019 at 10:32 am
(HealthDay)—For women with asthma, asthma exacerbation (AE) during pregnancy is associated with an increased risk for pregnancy complications, adverse perinatal outcomes, and early childhood ...
- Asthma Drugs Market Size, Share, Trend, Future Demand Analysis by 2019-2023 | Pfizer, GlaxoSmithKline, Novartis, Merckon November 27, 2019 at 8:15 am
Nov 27, 2019 (Reporthive Research via COMTEX) -- Chicago, United States, Nov 27, 2019 -- Report hive adds Asthma Drugs Market report to its research database. Delivering in depth market statistics, ...
- The Use of Heated Tobacco Products is Associated with Asthma, Allergic Rhinitis, and Atopic Dermatitis in Korean Adolescentson November 27, 2019 at 2:07 am
Multiple tobacco use had an association with the risk of each allergic disease. Use of each tobacco product was significantly associated with an increased risk of multi-morbidity of asthma, allergic ...
- Asthma Medication Market 2019 Global Industry Share, Demand, Top Players, Industry Size, Future Growth by 2025: Research Reports Worldon November 25, 2019 at 8:52 pm
Nov 26, 2019 (The Expresswire) -- Asthma Medication Industry 2019 Global Market research report provides key analysis on the market status of the Asthma Medication manufacturers with market size, ...
- FeNO may help diagnose cough variant asthmaon November 25, 2019 at 10:24 am
Forced exhaled nitric oxide, or FeNO, may be useful for diagnosing cough variant asthma in patients with chronic cough who have normal spirometry, researchers reported at the American College of ...
- UMass Lowell researcher receives $1 million grant for asthma prevention researchon November 24, 2019 at 8:48 am
A UMass Lowell researcher who works to alleviate asthma in senior citizens has received $1 million from the U.S. Department of Housing and Urban Development to advance his work. UMass Lowell Prof.
- Stable asthma patients and satisfied parents thanks to the Puffer appon November 22, 2019 at 7:10 am
Around 1,000 children with asthma are being treated at the Medisch Spectrum Twente. Young asthma patients visit the hospital for their check-ups three times a year on average. But that is a thing of ...
via Bing News